Famotidine serves as a histamine H2-receptor antagonist, effectively inhibiting the release of gastric acid. This action contributes to the symptoms of various gastrointestinal disorders, including peptic ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. Famotidine's therapeutic profile exhibits a relatively long half-